October 8, 2026
Vālenz Health® VP of Stop Loss Solution and Sales Ben Winfield and Executive VP of Stop Loss Operations discuss the current state of the stop loss market in Aug. 2026, including the impact of gene and cell therapies on underwriting, cost-containment and population health strategies to improve claim performance, and more.
Ready to Simplify Self-Insurance?
Connect with a Valenz team member to explore the difference our solutions can make for you.